Blue Trust’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
Blue Trust's ADMA Position: Q3 2026 in Review
Blue Trust sold out of ADMA Biologics (ADMA) in Q3 2026, closing a stake of 1,634 shares — an estimated $13.7K sold.
Blue Trust first reported a position in ADMA in Q1 2025 and held it in 6 quarters. The position peaked at $77.9K in Q4 2025. 266 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- Blue Trust reported no remaining ADMA Biologics position as of Q3 2026 after selling out during the quarter.
- Blue Trust sold 1,634 ADMA Biologics shares in Q3 2026, an estimated $13.7K.
- Blue Trust first reported a position in ADMA Biologics in Q1 2025 and held it in 6 quarters.
- Blue Trust's ADMA Biologics position peaked at $77.9K in Q4 2025.
- 266 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.